Keywords: actelion, beats, 1st-qtr, forecasts, swiss, biopharmaceutical, firm

Actelion beats 1st-qtr 2006 forecasts

Article | 01 May 2006

Swiss biopharmaceutical firm Actelion reported a set of extremely good first-quarter results, beating consensus forecasts. The group's total turnover grew 44% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

bosentan

Tracleer

Miglustat

Zavesca

Go to drug listing